Proprietary AI analyst is now available
- Public Comps
- M&G
M&G Valuation Multiples
Discover M&G's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Aditya Birla Capital, Korea Investment Holdings, Sanlam, Orient Securities and more.
M&G Overview
About M&G
M&G PLC is a United Kingdom-based company engaged in the savings and investments business. It serves retail customers, who want to build and protect their life savings, and provides investment solutions. The company's reportable segment are Asset Management segment offers investment management to both wholesale and institutional clients. The Life segment operates in the savings and pensions market and includes corporate risk and individual and international solutions. and The Corporate Centre segment includes central corporate costs and debt costs.
Founded
2018
HQ

Employees
8.5K
Website
Sectors
Financials (LTM)
EV
$13B
Valuation Multiples
Start free trialM&G Financials
M&G reported last 12-month revenue of $1B.
In the same LTM period, M&G generated $556M in net income.
Revenue (LTM)
M&G P&L
In the most recent fiscal year, M&G reported revenue of $29B and net income of $419M.
M&G is profitable as of last fiscal year, with net margin of 1%.
Financial data powered by Morningstar, Inc.
M&G Stock Performance
M&G has current market cap of $10B, and enterprise value of $13B.
Market Cap Evolution
M&G's stock price is $4.18.
M&G share price decreased by 1.7% in the last 30 days, and increased by 21.7% in the last year.
M&G has an EPS (earnings per share) of $0.18.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13B | $10B | -1.5% | -1.7% | 13.2% | 21.7% | $0.18 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialM&G Valuation Multiples
M&G trades at 8.7x EV/Revenue multiple.
EV / Revenue (LTM)
M&G Financial Valuation Multiples
As of June 5, 2026, M&G has market cap of $10B and EV of $13B.
M&G has a P/E ratio of 17.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified M&G Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


M&G Margins & Growth Rates
M&G decreased revenue by 95% but net profit grew by 77% in the last fiscal year.
In the most recent fiscal year, M&G reported net margin of 1%.
M&G Margins
M&G Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
M&G Operational KPIs
M&G's revenue per employee in the last FY averaged $3.4M.
Data powered by FactSet, Inc. and Morningstar, Inc.
M&G Competitors
M&G competitors include Aditya Birla Capital, Korea Investment Holdings, Sanlam, Orient Securities, Pershing Square Holdings, SEI Investments, Menora Mivtachim, Merlin Properties, Polar Capital Technology Trust and Sofina.
Most M&G public comparables operate across Asset Management.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 6.2x | 30.1x | 41.3x | 39.2x | |||
| 3.0x | 3.2x | - | - | |||
| 0.6x | 2.2x | 6.1x | 5.8x | |||
| 7.2x | 8.4x | - | - | |||
| 5.0x | - | - | - | |||
| 4.5x | 4.3x | 10.4x | 12.5x | |||
| 2.2x | - | - | - | |||
| 23.7x | 25.8x | 13.4x | 29.7x | |||
This data is available for Pro users. Sign up to see all M&G competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by M&G
M&G has acquired 3 companies to date.
Last acquisition by M&G was on November 4th 2024. M&G acquired BauMont for undisclosed valuation.
Latest Acquisitions by M&G
| Description | BauMont is a Miami-based real estate private equity firm investing in multifamily and industrial properties across the US Sunbelt. The company manages funds targeting value-add acquisitions in markets like Atlanta, Dallas, and Phoenix, partnering with institutional limited partners for developments exceeding 1,000 units. | Sandringham Financial Partners is a Bath-based wealth management firm offering investment advice, pension planning, mortgages, and inheritance tax services to UK clients. Regulated by the Financial Conduct Authority, the group manages discretionary portfolios through Sandringham Partners with assets under advice exceeding GBP 10 billion across 40 offices. It partners with Royal London for protection products. | Ascentric is a Bristol, UK-based digital platform for financial advisers managing wrap accounts and wealth portfolios. It administers over £6 billion in assets with tools for portfolio rebalancing, tax reporting, and ESG integration. The service connects to fund supermarkets and supports adviser consolidation under the SJP group. |
| HQ Country | |||
| HQ City | London | Huddersfield | Bath |
| Deal Date | 4 Nov 2024 | 18 Aug 2021 | 27 May 2020 |
| Valuation | undisclosed | undisclosed | undisclosed |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all M&G acquisitions and their M&A valuation multiples. Start Free Trial | |||
Investments by M&G
M&G has invested in 5 companies to date.
Latest investment by M&G was on February 17th 2025. M&G invested in Udaan in their $114M Series G round (EV/Revenue multiple available to Pro users).
Latest Investments by M&G
| Description | Udaan is a Bengaluru-based eB2B platform connecting suppliers and businesses in FMCG, pharmaceuticals, and staples categories across India. The service optimizes supply chain logistics and extends financial products to small retailers via udaan.com. | SeQura is a Barcelona-headquartered eCommerce payment provider founded in 2013. The company enables retailers to offer flexible options like immediate payments, buy now pay later, and installment plans in three payments, boosting conversion rates while guaranteeing merchant revenue. It processes transactions across Spain and expanding European markets, integrating with platforms such as Shopify and PrestaShop. | Nuclera is a Cambridge-based biotechnology company offering the eProtein Discovery system for rapid protein production. This automated platform enables researchers to synthesize milligrams of protein in days for drug discovery and structural biology. Serving academic labs and biopharma firms worldwide, Nuclera's technology accelerates hit validation in antibody and small molecule programs. Founded from University of Cambridge research, it operates cloud-connected bioprinters in the UK and US. | Apollo Therapeutics is a Cambridge-based drug discovery company established in 2016. It partners with Imperial College London, University College London, University of Cambridge, AstraZeneca, GlaxoSmithKline, and Johnson & Johnson to translate academic research into clinical candidates. The firm advances projects in oncology, neurodegeneration, and immunology, with two assets in Phase I trials by 2023. Apollo's team of 40 scientists provides medicinal chemistry, biology, and DMPK expertise, securing over £100 million in funding for its pipeline. | |
| HQ Country | |||||
| HQ City | Bangalore | Barcelona | Cambridge | Cambridge | |
| Deal Date | 17 Feb 2025 | 13 Nov 2024 | 15 Oct 2024 | 2 Jan 2024 | |
| Round | Series G | Undisclosed stage | Series C | Series C | |
| Raised | $114M | $434M | $75M | $34M | |
| Investors | Lightspeed Venture Partners; M&G | Chenavari Investment Managers; Citi; M&G | British Patient Capital; Cambridge Innovation Capital; E Ink Hldgs; Elevage Medical Technologies; GK Goh; Jonathan Milner; M&G; Michael McCreary; Patient Square Capital; Uni Power Group; Verve Ventures | M&G; Patient Square Capital; Rock Springs Capital | |
| Valuation | $2B | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all M&G investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout M&G
| When was M&G founded? | M&G was founded in 2018. |
| Where is M&G headquartered? | M&G is headquartered in United Kingdom. |
| How many employees does M&G have? | As of today, M&G has over 8K employees. |
| Who is the CEO of M&G? | M&G's CEO is Paolo Andrea Rossi. |
| Is M&G publicly listed? | Yes, M&G is a public company listed on London Stock Exchange. |
| What is the stock symbol of M&G? | M&G trades under MNG ticker. |
| When did M&G go public? | M&G went public in 2019. |
| Who are competitors of M&G? | M&G main competitors include Aditya Birla Capital, Korea Investment Holdings, Sanlam, Orient Securities, Pershing Square Holdings, SEI Investments, Menora Mivtachim, Merlin Properties, Polar Capital Technology Trust, Sofina. |
| What is the current market cap of M&G? | M&G's current market cap is $10B. |
| What is the current revenue of M&G? | M&G's last 12 months revenue is $1B. |
| What is the current revenue growth of M&G? | M&G revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of M&G? | Current revenue multiple of M&G is 8.7x. |
| What is the current net income of M&G? | M&G's last 12 months net income is $556M. |
| What is the current FCF of M&G? | M&G's last 12 months FCF is $185M. |
| What is M&G's FCF margin? | M&G's last 12 months FCF margin is 13%. |
| What is the current EV/FCF multiple of M&G? | Current FCF multiple of M&G is 68.2x. |
| How many companies M&G has acquired to date? | As of June 2026, M&G has acquired 3 companies. |
| What was the largest acquisition by M&G? | None of the M&A deals M&G has completed have disclosed valuations. |
| What companies M&G acquired? | M&G acquired Ascentric, BauMont, and Sandringham Financial Partners. |
| In how many companies M&G has invested to date? | As of June 2026, M&G has invested in 5 companies. |
| What was the last M&G investment? | On 17th February 2025 M&G invested in Udaan, participating in a $114M Series G round at $2B valuation, alongside Lightspeed Venture Partners. |
| In what companies M&G invested in? | M&G invested in SeQura, Udaan, Apollo Therapeutics, Nuclera, and Finance Ireland. |
See public comps similar to M&G
Lists including M&G
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.


